LUAD has the highest mortality of human cancers, and 30% of LUAD tumors harbor oncogenic KRAS mutations; however, the role of mitochondrial dynamics in this malignancy is poorly defined compared with other KRas-driven tumors. This evidence concerns the gene KRAS and cancer.